Use of the Contura™ Catheter in Intermediate-Risk, Pathological Stage 0, I, or II (Up to 3.0 cm) Breast Cancer Patients

This study has been completed.
Sponsor:
Collaborator:
SenoRx, Inc.
Information provided by (Responsible Party):
Cancer Center of Irvine
ClinicalTrials.gov Identifier:
NCT00882089
First received: April 15, 2009
Last updated: July 29, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2009
  Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)